For NCBP2 is one of the genes that is closely related to the prognosis of acute myeloid leukemia (AML), the risk score and nomogram results on pediatric AML research suggested that NCBP2 may be a risk factor for the malignant tumor (Zhang et al., 2022). This evidence concerns the gene NCBP2 and acute myeloid leukemia.